Dixon Robert L JR 4

What Happened Robert L. Dixon Jr., a director of Elevance Health, Inc. (ELV), was granted 563 deferred stock units on May 13, 2026. The units were awarded at $0.00 per unit (total reported value $0) as part of the Company's Board of Directors compensation program. This was an award/grant (code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-13; transaction type: Grant/Award (A); amount: 563 units; price: $0.00.
• Filing: Form 4 filed 2026-05-15 for the 2026-05-13 grant — appears to be timely (filed within the usual two-business-day window).
• Shares owned after transaction: not disclosed in this filing.
• Footnotes: (F1) Units are deferred stock units under the Board compensation program. (F2) Units will be payable in Company common stock upon the earlier of (a) five years from grant or (b) the director’s departure from the board, unless a different date was elected under the Deferred Compensation Plan.

Context Deferred stock unit awards to directors are a routine form of non-cash compensation that convert into company shares at a future date or upon exit from board service. Such grants align director pay with shareholder interests but do not involve an immediate cash purchase or sale and do not by themselves indicate the director’s private trading sentiment.